Back to search results

Intravenous Iron for Iron Deficiency in Scoliosis Surgery

This study is looking at whether giving intravenous iron (Ferric carboxymaltose IV) before spinal fusion surgery for scoliosis can reduce the need for blood transfusions. You might be able to join if you are 10-19 years old, have scoliosis or kyphosis, are scheduled for spinal fusion surgery at MS-CHONY within six weeks, and have iron deficiency (low serum ferritin levels). Some people will receive Ferric carboxymaltose IV, while others will receive Normal Saline (a placebo). The main goal is to see how many people need a red blood cell transfusion during or after surgery, up to 30 days later. The study aims to enroll 120 participants, but its current status is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It is a randomized controlled trial, comparing Ferric carboxymaltose IV to a placebo (Normal Saline).
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, incidence of perioperative RBC transfusion, is measured at 4-30 days after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07217873

IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study

Recruiting
PHASE2Ages 10–19InterventionalPrevention
Columbia University
~120 participants
Updated 2025-11-26 on ClinicalTrials.gov
What's tested:Ferric carboxymaltose IVNormal Saline (Placebo)

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Incidence of perioperative RBC transfusion in iron deficient scoliosis patients undergoing spinal fusion
Measured over 4-30 days

Conditions

Scoliosis Correction
Iron Deficiency
Transfusion Blood
Surgery Complications
Spinal Fusion
Scoliosis Idiopathic Adolescent
Scoliosis Neuromuscular

Explore related trials

KyphosisScoliosisFerritin

NCT07217873

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Columbia University Irving Medical Center

    New York, New Yorkno site contact published

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

Lisa D Eisler, M.D.
[email protected]
212-305-2413
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

10 -19 years old
diagnosis of scoliosis or kyphosis
scheduled for imminent spinal fusion procedure (\<6 weeks) at MS-CHONY
Iron deficiency or hypoferritinemia, defined as serum ferritin less than or equal to 50 μg/L

Exclusion

C-reactive protein \> 10 mg/L
receiving nutritional support by report in the medical chart
self-reported history of hypersensitivity reaction to iron-containing supplements
self-reported history of receiving intravenous iron supplements
self-reported history of iron overloaded state such as hereditary hemochromatosis or hemosiderosis
objection to receiving red blood cell transfusions
current pregnancy (identified by self-report or documentation of preoperative screening test in the medical record)
prisoners
patient or parent decides against study participation

What this trial measures

  • Incidence of perioperative RBC transfusion in iron deficient scoliosis patients undergoing spinal fusion4-30 days

    The patients that received a red blood cell transfusion either during procedure or postoperatively during their surgical hospitalization will be tallied.